NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹102 Cr | ₹198 Cr | ₹161 Cr | ₹76 Cr | ₹89 Cr |
What is the latest Contingent Liabilities ratio of NECTAR LIFESCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹102 Cr |
| Mar2024 | ₹198 Cr |
| Mar2023 | ₹161 Cr |
| Mar2022 | ₹76 Cr |
| Mar2021 | ₹89 Cr |
How is Contingent Liabilities of NECTAR LIFESCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹102 Cr | -48.56 | |
| Mar2024 | ₹198 Cr | 22.75 | |
| Mar2023 | ₹161 Cr | 113.41 | |
| Mar2022 | ₹76 Cr | -15.46 | |
| Mar2021 | ₹89 Cr | - | |
Compare Contingent Liabilities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹214.5 Cr | -1% | -5.7% | -34% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -1% |
-5.7% |
-34% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses